Three cases of abnormal fibrinogens: Šumperk (Bβ His67Leu), Uniãov (Bβ Gly414Ser), and Brno (γArg275His)

• References

• 1 Henschen AH, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Blood Coagulation. Am sterdam. Elsevier Science Publishers; 1986: 171-241.
• 2 Kant JA, Fornace AJ, Saxe D. et al. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-2348.
• 3 Hanss M, Biot F. A Database for Human Fibrinogen Variants. Ann N Y Acad Sci. 2001 936. 89-90 http://www.geht.org/databaseang/fibrinogen (September 2008, release 28)
• 4 Hill MB, Brennan SO, Dear A. et al. Fibrinogen Nottingham II: A novel B β Arg264gly substitution causing hypofibrinogenaemia. Thromb Haemost 2006; 96: 378-380.
• 5 Sheen CR, Low J, Joseph J. et al. Fibrinogen Darlinghurst: Hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Thromb Haemost 2006; 96: 685-687.
• 6 Monaldini L, Asselta R, Duga S. et al. Mutational screening of six afibrinogenemic patients: Identification and characterization of four novel molecular defects. Thromb Haemost 2007; 97: 546-551.
• 7 Brennan SO, Davis RL, Mosesson MW. et al. Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a γ320Asp deletion at the Ca2+ binding site. Thromb Haemost 2007; 98: 467-469.
• 8 Davis RL, Brennan SO. Fibrinogen Tolaga Bay: A novel γAla341Val mutation causing hypofibrinogenaemia. Thromb Haemost 2007; 98: 1136-1138.
• 9 Flood VH, Al-Mondhiry HA, Rein CM. et al. Fibrinogen Hershey IV: A novel dysfibrinogen with a γV411I mutation in the integrin αIIbβ3 binding site. Thromb Haemost 2008; 99: 1008-1012.
• 10 Kotlín R, Chytilová M, Suttnar J. et al. A novel fibrinogen variant– Praha I: hypofibrinogenemia associated with γ 351 Gly → Ser substitution. Eur J Haematol 2007; 78: 410-416.
• 11 Kotlín R, Chytilová M, Suttnar J. et al. Fibrinogen Nový Jiãín and Praha II: Cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Thromb Res 2007; 121: 75-84.
• 12 Kotlín R, Sobotková A, Suttnar J. et al. A novel fibrinogen variant – Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution. Eur J Haematol 2008; 81: 123-129.
• 13 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246.
• 14 Vu D, Bolton-Maggs PHB, Parr JR. et al. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood 2003; 10: 4413-4415.
• 15 Czwalinna A, Lennemann K, Varvenne M. et al. Detection of expression of three missense mutations in the Bb fibrinogen gene resulting in a and/or hypofibrinogenemia. J Thromb Haemost 2005; 03: 1377.
• 16 Duga S, Asselta R, Santagostino E. et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000; 95: 1336-1341.
• 17 Monaldini L, Asselta R, Duga S. et al. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bβ-chain gene. Haematologica 2006; 91: 628-633.
• 18 Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389: 455-462.
• 19 Imafuku Y, Tanaka K, Takahashi K. et al. Identification of a dysfibrinogenemia of γR275C (Fibrinogen Fukushima). Clin Chim Acta 2002; 325: 151-156.
• 20 Zhang JZ, Redman CM. Identification of B beta chain domains involved in human fibrinogen assembly. J Biol Chem 1992; 267: 21727-21732.